TrialDrugs in R&D2016

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus.

Changyu Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.